Significantly more patients in the clonidine group than in the placebo group had clinically important hypotension ( 2385 patients [ 47.6 % ] vs. 1854 patients [ 37.1 % ] ; hazard ratio 1.32 ; 95 % CI , 1.24 to 1.40 ; P < 0.001 ) .